Authors


Olivia G. Funk, PharmD Candidate

Latest:

Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common Cold

Despite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.


Shams Alrubaie, PharmD Candidate

Latest:

New Advances in Breast Cancer Therapy

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.


David Hutton

Latest:

Two Eye Diseases Could Contribute to Common Blinding Eye Condition

The study could lead to early diagnosis and treatment of age-related macular degeneration.


Lauren Jonas, MD

Latest:

Preventing Severe Respiratory Infections in Children

A refresher on best interventions for common respiratory disorders in children.


Ollin Sykes, CPA, CITP

Latest:

Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.


Bonnie Bond, CPA

Latest:

Maximizing Adherence Packaging for Patient Health and Pharmacy Growth

Is adherence packaging technology a big investment for a community or independent pharmacy?


Carrie W. Nemerovski, PharmD

Latest:

OTC Drug Interaction Considerations in the Cough and Cold Aisle

OTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.


Kris Rhea

Latest:

Focus on What Matters: Sustaining Your Pharmacy in 2025

What are some key strategies for keeping your pharmacy thriving in 2025?


Janessa Maldonado, PharmD candidate

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


Ariana Pelosci

Latest:

Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference Product

Findings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.


Thomas W. Laudone, PharmD, BCPPS

Latest:

Case Study: Treating Infants for Cannabis Exposure

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.


Rachel H. Alinsky, MD, MPH

Latest:

Cannabinoid Hyperemesis Syndrome: Diagnosis and Management

A deep dive for pharmacists into this frequently debilitating disorder


Alisha Reed, PharmD

Latest:

Pharmacists Discuss Their Hopes for the Future of Pharmacy in 2025 | APhA 2025

Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.


Katie Hobbins

Latest:

Creating A Successful Social Media Presence

Social media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.


Matthew Fowler

Latest:

COVID-19 Vaccines: T Cell, Antibody Responses Demonstrated in CLL

Patients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.


Oriana Lerner

Latest:

Breaking Down the Numbers for Isotretinoin AEs

Recent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.


Maggie L. Shaw

Latest:

Biosimilars Are Bringing Affordability and Accessibility

Lower costs, increased availability, and assistance programs are “game changers” for patients.


Robert Calandra

Latest:

Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?

Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.


Madeleine Depinho, BS, PharmD Candidate 2022

Latest:

New Drug Review: Atogepant FDA-Approved for Migraine Treatment

On September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.


Jasmine Cutler, PharmD, CPh

Latest:

Scripted for Her: Helping Patients Choose Contraceptive Methods

In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.


Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES

Latest:

The Pharmacist’s Role in Counseling Patients on GLP-1 Medications

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.


Egla Hasimllari, PharmD

Latest:

DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adults

This new drug utilizes the bactericidal properties of taurolidine and the bloodthinning effects of heparin to maintain catheter patency.


Tom Knight, MBA, MS

Latest:

Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget Cuts

With the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.


Tracy D Mahvan, RPh, PharmD, MBA, BCGP

Latest:

OTC Considerations for COVID-19

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves


Kathy Blanchard

Latest:

Focus on DIR Fees: 3 Ways to Manage Them

When investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.


Bridget Hanna, CPhT

Latest:

Do’s And Don’ts: Social Media Tips for Pharmacists

Social media marketing is a powerful tool that pharmacists can use.


Sandhya Vijapurapu, PharmD Candidate

Latest:

Digital Health Tools in Diabetes

Technology and mobile health apps can be valuable tools in diabetes management.


Caitlyn Bradford, PharmD

Latest:

Navigating Pediatric ADHD Medication Shortages

Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.


Reina Puri

Latest:

Best Practices on Discussing Birth Control for Adolescents

There are numerous methods of contraception available for adolescents.


Susan Cornell, PharmD, CDCES, FAPhA, FADCES

Latest:

Pharmacists Discuss Their Hopes for the Future of Pharmacy in 2025 | APhA 2025

Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.

© 2025 MJH Life Sciences

All rights reserved.